According to the latest report by IMARC Group, titled “China Genetic Testing Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, the China genetic testing market reached a value of US$ 2.76 Billion in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 16.8% during 2021-2026.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report
Request for a PDF sample of this report: https://www.imarcgroup.com/china-genetic-testing-market/requestsample
In an effort to expand its domestic biotechnology sector, the Chinese Government has taken steps in the favor of genetic science development. It identified genomics as a strategic field for the country’s social and economic development in its 14th Five-Year Plan. The Government also plans to document the genetic makeup of people from nine different minority groups, in an attempt to decode hereditary information within their genes. Apart from this, the market for direct-to-consumer DNA testing has also experienced massive growth driven by rising priority of personal health and wellness among consumers. This trend has further been supported by technological advancements which have reduced the cost of DNA sequencing services. However, there is a lack of specifically-designed educational programs for training medical genetic professionals in China.
- On the basis of test type, the market is segmented into prenatal testing, newborn testing, diagnostic testing, carrier testing, predictive or presymptomatic testing and others. Amongst these, prenatal testing is the most popular segment.
- Based on diseases, the market has been segregated into cancer, Down syndrome, thalassemia and others. At present, cancer remains the leading cause of death in China owing to which genetic tests are gaining popularity as these tests help the doctors in identifying suitable medication for patients.
- The market has been categorized on the basis of technologies into cytogenetic, biochemical and molecular. Amongst these, biochemical is the most common technology used for conducting genetic tests in China.
- There are several service providers available in China for genetic testing such as hospital-based laboratories, independent laboratories and specialty clinics. Hospital-based laboratories exhibit a clear dominance in the market.
- The report has analyzed the China genetic testing market according to different testing samples which include blood, saliva, hair and others. Amongst these, blood samples hold the majority of the market share.
- The competitive landscape of the market has also been examined with some of the key players being BGI, Shenzhen Huada Gene Technology Co Ltd., Berry Genomics Co. ltd., Daan Gene Co. Ltd, WuXi NextCODE, Annoroad Gene Technology Co. Ltd and WuXi PharmaTech.
- Berry Genomics Co. ltd.
- Daan Gene Co. Ltd
- WuXi NextCODE
- Annoroad Gene Technology Co. Ltd.
- WuXi PharmaTech
Breakup by Test Type:
- Prenatal Testing
- Carrier Testing
- New Born Testing
- Predictive/Presymptomatic Testing
- Diagnostic Testing
Breakup by Disease:
- Down Syndrome
Breakup by Technology:
Breakup by Service Provider:
- Hospital Based Laboratories
- Independent Laboratories
- Specialty Clinics
Breakup by Testing Sample:
Ask Analyst for Customization and Explore full report with TOC & List of Figures: https://www.imarcgroup.com/china-genetic-testing-market
We are updating our reports, If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours.
Key highlights of the report:
- Market Performance (2015-2020)
- Market Outlook (2021-2026)
- Market Trends
- Market Drivers and Success Factors
- The Impact of COVID-19 on the Global Market
- Value Chain Analysis
- Structure of the Global Market
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
Related Reports by IMARC Group:
Anhydrous Milk Fat Butter Oil Market Price Trends: Global Industry Share, Size, Growth, Opportunity and Forecast 2021-2026
Ultrasonic Flowmeter Market Share: Industry Trends, Size, Growth, Opportunity and Forecast 2021-2026
Automotive NVH Materials Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026
Battery Management System Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026
GCC Oral Hygiene Market : Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026
Europe PVC Pipes Market Size: Industry Trends, Share, Growth, Opportunity and Forecast 2021-2026
Cosmetic Implants Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026
Medical Simulation Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026
Smart Mirror Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026
HPMC Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise
IMARC Group 30 N Gould St Ste R Sheridan, WY 82801 USA – Wyoming Email: [email protected] Tel No:(D) +91 120 433 0800 Americas: – +1 631 791 1145 | Africa and Europe: – +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800